Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)

NCT03141671 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

345

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: GnRH
DRUG: Bicalutamide
RADIATION: Salvage radiation
DRUG: Abiraterone
DRUG: Prednisone
DRUG: Apalutamide

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]